| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0006 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.16 | 0.004 |